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Exposure of humans to ozone (03; 0.1-0.6
o3
~~ ~ ~~~ ppm)~~~for 2-6.6 hr can result in a lung
inflammatory response as evidenced by an
influx of polymorphonuclear leukocytes
(PMN) into the airways (1-3). Addition-
ally, a number of other immune cell func-
tions can be altered upon 03 exposure.
.........A ed~ For example, a depression in mitogen-
stimulated peripheral blood T-lymphocyte
~proliferation was observed in humans
exposed to 0.4-0.6 ppm 0 for 2-4 hr
(4 -6). 0 exposure in vitro of human
peripheral blood mononuclear cells inhib-
ited T-lymphocyte proliferation and de-
~~~~~creased interleukin-2 and IgG production
Human peripheral blood natural killer
(NK) cells exposed in vitro to 0.18-1.0
0 for 4 hr demonstrated decreased
cytotoxicity against K562 tumor cells (8).
~Rodents exposed in vivo to 0.5-1.0 ppm
for day (9) or 1.6 ppm for 7 days
(10) also demonstrated decreased lung NK
activity
ralArachidonic acid (AA) is a polyunsatu-
*)d~~'~ rated fatty acid that is found in lung cells
.....aea~Istnrlirree and in airway lining fluid either free or
esterified to phospholipids (11). We have
previously shown that in a cell-free in vitro
miogeo~ exposure system, 0 can degrade AA to
more polar products (12). Additionally,
exposure of rats to 2.0 ppm 0 in vivo for
i~ 4 hr has been reported to degrade AA in
~the lung (13). The products of 0 -n
duced degradation of fatty acids in aqueous
solutions have been reported to include
carbonyl compounds (aldehydes and ke-
tones), ozonides, and peroxides (14-16).
Some of the observed responses of
immune cells to 03 exposure in vivo and
in vitro (e.g., neutrophil influx, decreased
lymphocyte proliferation, suppressed NK
cytotoxicity) may be mediated by 03
induced AA degradation products. For
example, long-chain aldehydes have been
shown to be potent chemoattractant agents
for rat polymorphonuclear leukocytes
........(PMNs) (17,18). Hydrogen peroxide
(H202) has been reported to inhibit hu-
man peripheral blood T-lymphocyte pro-
...............liferation (19) and NK cell lysis of K562
tumor cells (20). We therefore examined
whether the degradation products of AA
3
biological activity using assays that assess
PMN polarization (which is an indicator
of the chemokinetic and/or chemotaxic
potential of a substance), PMN superoxide
anion (09- production, lymphocyte pro-
liferation, and NK cytotoxicity. We also
examined the chemical nature of the O3-
induced AA degradation products and the
effect of 03 exposure in vitro on the for-
mation of these products by a human
bronchial epithelial cell line.
Methods
Materials
AA (sodium salt; 99% purity), catalase
(bovine liver), superoxide dismutase (SOD;
bovine erythrocyte), N-formyl-methionine-
leucine-phenylalanine (fMLP), H202,
reduced glutathione (GSH), GSH peroxi-
dase (bovine erythrocyte), ferricytochrome
c (horse heart), 2,4-dinitrophenylhydrazine
(DNPH), dextran sulfate (500,000 average
molecular weight), and phenol-red-free
Hank's balanced salt solution (HBSS) with
Ca2+ and Mg2+ were purchased from Sigma
Chemical Company (St. Louis, MO). DH-
AA (60-100 Ci! mmol, >98% cis form, tri-
tium attached to carbon in positions
5,6,89,11,12,14, and 15 ) and H-thymi-
dine (20 Ci/mmol) were obtained from
New England Nuclear (Boston, MA).
Phosphate-buffered saline (PBS; Ca2+and
Mg2+ free) and RPMI medium were pur-
chased from Hazelton Laboratories
(Lexena, KS) or JRH Biosciences (Lexena,
KS). Ficoll-Hypaque was purchased from
Organon-Teknika (Durham, NC). Kera-
tinocyte growth medium was purchased
from Clonetics Corp. (San Diego, CA).
Six- (35- mm2diameter/well) and 96- (0.32
cm2/ well) well plastic tissue culture plates
were purchased from Costar (Cambridge,
MA). Phytohemagglutinin (PHA) and
concanavalin A were purchased from Bur-
roughs-Wellcome (Research Triangle Park,
NC).
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Exposure ofAA Solutions to 03
AA (30 PM) in 500 p1 PBS, or PBS alone,
was added to 35-mm wells and exposed to
air or 03 (0.1 or 1.0 ppm) for up to 120
min. We chose these 03 concentrations
to examine the AA degradation products
formed with very low and very high con-
centrations of the oxidant gas. We main-
tained 03 concentrations within ± 10%
and ± 20% of the 1.0 ppm and 0.1 ppm
concentrations, respectively. In some
experiments requiring radioactive AA as a
tracer compound, H-AA in ethanol was
added to a polypropylene tube and the
ethanol evaporated under N2 (370C). We
then added the unlabeled 30 jiM AA solu-
tion to the 3H-AA (0.2 Ci/ml final con-
centration; approximately 2.5 nM), soni-
cated the solution (30 sec) in a water bath
sonicator (Fisher Scientific), and vigorous-
ly agitated the solution before exposure to
air or 03. Exposures were performed in a
humidified rocking in vitro exposure sys-
tem (370C, 95% relative humidity, 5%
CO2) previously described in detail (7,
20,21). Room air was filtered through a
high-efficiency particle air filter (to re-
move particulates) and an activated char-
coal filter (to remove gaseous pollutants)
and was pumped into the air (no 03)
exposure chamber or was passed through a
metal chamber containing a UV light
source that produced 0 Oxides ofnitro-
gen were not detectable in the exposure
chamber atmosphere. After exposure,
solutions were removed from the exposure
chambers and used in cell bioassays or
analyzed for hydroperoxides and/or car-
bonyl compounds. In studies designed to
examine the reactivity of 03-exposed AA
with GSH, solutions of 03-exposed AA
(900 p1) were incubated (60 min, 370C)
with GSH (100 pl in PBS with pH adjust-
ed to 7.4; final GSH concentrations of
1-100 mM) or 10 mM GSH with GSH
peroxidase (5 U/ml). In some experi-
ments, we incubated solutions (60 min,
370C) with catalase (120 U/ml) and SOD
(107 U/ml) and/or ethanol (1 mM) to
scavenge H202, 02-, and hydroxyl radical,
respectively, before adding the solutions to
bioassays. The recovery oftritium derived
from 3H-AA in the air-exposed and 03-
exposed wells was >50% and >70%, re-
spectively. The radioactive solutions were
then analyzed for the presence of car-
bonyl-containing compounds by HPLC.
HPLCAnalysis ofCarbonyl
Compounds
We incubated solutions (500 p1) contain-
ing 3H-AA that had been previously ex-
posed to air or 03 for 60 min in the dark
with 100 p1 HCl (12 M) and 500 p1 ace-
tonitrile with orwithout DNPH (0.125%).
DNPH has been reported to selectively
react with carbonyl moieties, i.e., aldehy-
des and ketones (22). Aliquots of each
sample were then injected into an HPLC
system which consisted oftwo 510 pumps,
a WISP 712 autosampler, a Systems
Interface Module, and a Maxima 820 soft-
ware program (Waters' Associates, Milford,
MA). We separated tritiated substances
using a modified version of a previously
published reverse-phase method (23) and a
gradient from 60/40 acetonitrile/ water to
100% acetonitrile over 45 min at 1.0
ml/min flow rate through a Beckman/
Altex 5 jM ODS silica column (Rainin
Instruments, Woburn, MA). For the pur-
poses of this report we have termed this
HPLC system 1. Eluting radioactivity was
monitored using a flow-through scintilla-
tion counter (Radiomatic Instruments,
Tampa, FL) pumping scintillation cocktail
at 3.0 ml/min with automatic quench cor-
rection ofthe radioactivity.
Peroxide Analyses
The amount of lipid peroxides in 03-
exposed AA solutions or media from 03-
exposed BEAS cells was determined using a
commercial kit (Determiner LPO, Kamiya
Biomedical Company, Thousand Oaks,
CA) that measures the formation ofmeth-
ylene blue via the hemoglobin-catalyzed
reaction of a methylene blue derivative
(10-N-methylcarbamoyl-3,7-dimethy-
lamino-10-hydroxyphenothiazine; MCDP)
with lipid peroxides. Formation of meth-
ylene blue was monitored spectrophoto-
metrically at 660 nm, and cumene hydro-
peroxide was used as a standard. H202
(50 pM) did not react with MCDP. We
determined H202 using the horseradish
peroxidase-catalyzed oxidation of phenol
red, indicated by a change in absorbance at
610 nm (24).
Exposure ofa Human Bronchial
Epithelial Cell Line to Ozone
Characteristics of BEAS-2B cells (S6 sub-
clone; hereafter referred to as BEAS cells)
have been previously described (25,26) and
were generously provided by Curtis Harris
and John Lechner (National Institutes of
Health, Bethesda, MD). Briefly, human
bronchial epithelial cells were transformed
with an Ad12-SV40 construct. This cell
line is differentiation sensitive to trans-
forming growth factor and serum, can pro-
duce mucuslike glycoproteins, and con-
tains cytokeratin. We seeded BEAS cells
(passages 79-99) at 5 x 105 cells on colla-
gen-coated filters (24 mm diameter; 3 ,um
pores) in a Transwell-COL system (Costar,
Cambridge, MA) with 1.0 ml and 2.0 ml
keratinocyte growth medium in the apical
and basolateral compartments, respectively,
as previously reported (27). We changed
media on day 2 ofculture, and then on day
4 ofculture, we added 2 jCi 3H-AA in 1.0
ml keratinocyte growth medium to each
well in the apical compartment. On day 5,
we removed unincorporated 3H-AA, wash-
ed cells twice with HBSS, and exposed cul-
tures to air or 0 (0.1 or 1.0 ppm) for 60
min with 1.6 m? HBSS in the basolateral
compartment, using the same in vitro ex-
posure system as described previously but
without rocking. At the end of the expo-
sure, cells were removed from the exposure
system, 1.0 ml HBSS was added to the api-
cal compartment, and the cells were incu-
bated an additional 5 min at 370C and 5%
CO2. We then removed conditioned
media (keeping the apical and basolateral
compartment media separate from each
other), centrifuged the media (300g, 5
min, 4°C), added the supernatants to
ethanol (80% alcohol final concentra-
tion), and cooled the mixture (-80°C).
Precipitated proteins were removed by cen-
trifugation (500g, 20 min, 10°C), the
supernatants were dried by Speed Vac
evaporation (Savant, Farming-dale, NY)
and redissolved in 500 p1 5% methanol
initially, and then the tube was reextracted
with 500 gl 95% methanol, and the
extracts were combined (tritium extraction
efficiency >65%). We incubated 450 p1 of
the supernatant with acidified DNPH and
an equal volume with vehicle (acidified
acetonitrile) in a similar manner as the 03-
exposed AA solutions. The solutions were
injected into the HPLC system described
previously but using different separation
conditions (28) that employed a reverse-
phase methanol-water-acetic acid gradient
separation over 100 min. We term this
second separation system HPLC system 2
for the purposes ofthis report.
Peripheral Blood Leukocyte Isolation
Human peripheral blood cells were initially
separated using a standard Ficoll-Hypaque
gradient separation technique (29). For
isolation of PMN, we removed cells from
the appropriate layer, added them to 6%
dextran (in PBS) for 45 min, and removed
the top layer containing the PMN. Resid-
ual erythrocytes were lysed twice in 5 ml
ice-cold, sterile distilled water, and iso-
tonicity was restored with an equal volume
of 1.8% saline and then 40 ml PBS after
each hypotonic lysis. PMN viability was
95% as assessed by the trypan blue dye
exclusion assay, and there was <5% ery-
throcyte contamination. For isolation of
T-cell lymphocytes, we removed the
mononuclear cell layer from the Ficoll-
Hypaque gradient, and most monocytes
were removed by adherence to plastic tis-
sue culture dishes (1 hr at 37 C in 5%
CO2). We then used nonadherent cells for
T-cell proliferation assays. For isolation of
NK cells, the nonadherent mononuclear
Volume 101, Number2, June 1993 155cells were passed through nylon wool
columns (30) and the nonadherent cells
collected for NK assays.
Cell Bioassays
Polarization was assessed using a modifi-
cation of a previously published method
(31). PMN were adjusted to 1 X 106
cells/ml in HBSS. We added 900 j.d of
the cell suspension to 100 gl of a test
solution (resulting in a 1/10 dilution of
the test solution) and incubated it at
370C for 10 min with shaking. Cells
excluded >95% trypan blue after the
incubation period with all solutions test-
ed. Cells were then fixed by the addition
of 1.0 ml ice-cold 3.7% (v/v) formalde-
hyde in PBS. We counted a minimum of
200 cells for polarization by standard
light microscopic techniques. Duplicate
variability averaged <9%. To confirm
that the PMN had undergone a shape
change in the presence of a test solution,
the forward-angle light scatter of a sam-
ple was determined using standard flow
cytometric techniques using an Epics 5
Counter (Coulter Corp., Hialeah, FL)
with a 1-190 fixed angle of light collec-
tion. Human blood PMN have been
shown to have a decrease in forward-
angle light scatter when exposed to
chemotactic agents (32).
We measured PMN 02- formation
using the SOD-inhibitable reduction of
ferricytochrome c (33). We incubated
PMN (1 x 105) in 490 pl HBSS with
250 p1 of a test solution, 250 p1 of ferri-
cytochrome c (final concentration of 80
gM), and 10 pl SOD (320 U/ml final
concentration) or 10 pl HBSS in poly-
propylene tubes at 37°C with shaking for
60 min. In some experiments, PMN were
preincubated with 03-exposed AA solu-
tions for 60 min before the addition of
stimuli. Tubes were then centrifuged
(500g, 5 min, 40C), and the absorbance
of the supernatant was measured at 550
nm.
To assess T-lymphocyte proliferation,
we incubated 1 x 106 nonadherent cells/
ml PBS in polypropylene tubes for 30-
60 min (37 C, 5% C02) with an equal
volume of a test solution that had been
previously filtered (0.22 gim) to prevent
microbial contamination of the cell cul-
tures. In separate experiments, recovery
of the 03-exposed AA after filtration was
>80% based on the percentage of O3-
exposed 3H-AA that passed through the
filter. Cell viability after the preincuba-
tion period was 92 ± 2%, 77 ± 7%, and
80 ± 4% for cultures incubated with PBS
alone, 03-exposed AA (1.0 ppm x 120
min), and 03-exposed PBS (1.0 ppm x
120 min), respectively (p = NS among
the three groups). After the preincuba-
tion period, 100-pl aliquots of the cell
suspension were transferred to a 0.32-
cm well, and 100 p1 RPMI media with
gentamicin (40 pg/ml) and 20% fetal calf
serum and 50 p1 RPMI with 10% fetal
calfserum containing either concanavalin
A (5 pg/ml final concentration) or PHA
(0.6 pg/ml final concentration) or vehicle
alone were added. We assayed samples in
quadruplicate. Cultures were incubated
for 72 hr, and then proliferation was
assessed by 3H-thymidine incorporation
for 18 hr as previously described (7).
To assess NK cytotoxicity, nonadher-
ent lymphocytes (2.5 x 10 /ml PBS)
were incubated with an equal volume ofa
test sample for 1 hr (370C, 5% C02) and
centrifuged (500g, 5 min, 230C). We
then aspirated the supernatant and resus-
pended the cells in RPMI with 10% fetal
calf serum. The NK activity of the cells
was assessed in a standard 4-hr cytotoxic-
ity assay against K562 target cells using
effector:target ratios from 50:1 to 1.8:1
as previously described (34). We assayed
all samples in triplicate, and data are
expressed as lytic units at the LUIO value
(10% specific cytotoxicity level) calculat-
ed by regression analysis (35).
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The effect of 03-exposed AA on the
ability of NK cells to bind to K562 tar-
get cells was determined using a modifi-
cation of a previously published method
(36). We added 0.2 x 10 NK cells to an
equal number of K562 cells in a total
volume of 400 ml RPMI with 10% fetal
calf serum, centrifuged the cells (300g, 5
min, 230C), and removed 200 ml super-
natant. Cells were incubated for 15 min
(370C, 5% C02), and then cells were
pipetted three times to disrupt sponta-
neous conjugate formation. We then
determined cell conjugates in duplicate
by standard light microscopic enumera-
tion.
All data are expressed as means ±
SEM. A t-test for paired variates was
used for all analyses. Values of p<0.05
are considered significantly different
(37).
Results
Products of03-exposedAA
AA (containing 3H-AA) was exposed to air
or 0, incubated with acidified DNPH or
vehicle, and then analyzed by HPLC (sys-
tem 1). AA exposed to air for 120 min
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Figure 1. HPLC radioactivity profile of 2,4-dinitrophenylhydrazine (DNPH)-reactive products of 3H-arachi-
donic acid (AA) exposed to air or 03. AA (30 rM) in phosphate-buffered saline with 3H-AAtracer present
was exposed to air or 03,the solutions were removed, incubated with DNPH orvehicle (acidified acetoni-
trile), and injected into HPLC system 1. See text for more details. AA exposed to air (120 min) and incu-
bated with (A) vehicle or (B) DNPH. AA exposed to 0.1 ppm 03for 30 min and incubated with (C) vehicle
or (D) DNPH. AA exposed to 1.0 ppm 03 for 120 min and incubated with (E) vehicle or (F) DNPH.
Chromatograms aretypical for n2> 5 separate experiments.
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and then incubated with vehicle only elut-
ed with a retention of approximately 38
min (Fig. IA). Air-exposed AA incubated
with DNPH eluted with a similar reten-
tion time (Fig. 1B). In contrast, almost all
of the radioactivity associated with 03-
exposed AA (0.1 ppm for 30 min) that was
incubated with vehicle eluted in the HPLC
system as a polar peakwith an approximate
retention time of 4.5 min (Fig. IC), sug-
gesting that 03 degraded AA. HPLC
chromatograms of the 0.1 ppm 03-ex-
posed AA that was incubated with DNPH
demonstrated the presence of five major
peaks (peaks I-V; Fig. ID). Therefore,
03-exposed AA (0.1 ppm for 30 min)
reacted with DNPH as evidenced by a shift
in retention times of some of the radioac-
tivity in the chromatograms and as evi-
denced by the fact that these products con-
tain carbonyl moieties. Chromatograms of
1.0 ppm 03-exposed AA (120 min) incu-
bated with vehicle (Fig. 1E) showed the
presence ofa polar, degraded AA peak that
eluted with a similar retention time as the
0.1 ppm 03-degraded AA solution. The
chromatograms of 1.0 ppm 03-AA (120
min) incubated with DNPH (Fig. IF)
showed the presence oftwo major peaks (I
and II), of which peak II had a different
retention time from the radioactivity
exhibited in the chromatograms ofvehicle-
incubated solutions. These chromato-
graphic data show that the quantity and
types of products in the 1.0 ppm 03-AA
solution (120 min) were different from the
products in the 0.1 ppm (30 min) 03-AA
solutions.
The chemical stability of the carbonyl
compounds was assessed next. AA, ex-
posed to 0.1 ppm for 30 min, was either
immediately incubated with DNPH after
exposure or left at 220C for 24 hr in the
dark (in a tightly capped polypropylene
tube) before incubation with DNPH.
Analysis of the resulting products by
HPLC was performed immediately after
DNPH incubation. HPLC analysis
showed that there was <16% decrease in
the radioactivity associated with peaks
II-V, with a slight increase (5%) in the
radioactivity associated with the peak I
(data not shown).
The ability of the antioxidant GSH to
react with the 03-exposed AA was then
tested. AA (exposed to 0.1 ppm 03 for 30
min) that was preincubated with vehicle (0
mM GSH) or 1 mM GSH and then react-
ed with DNPH produced five major peaks
(Fig. 2A, B). Incubation of 03-exposed
AA with 10 mM GSH decreased the ra-
dioactivity 38%, 29%, and 36% in peaks
III, IV, and V, respectively, with peak I
increasing 220% and peak II remaining
unchanged (Fig. 2C). Incubation of 03-
exposed AA with 100 mM GSH removed
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Figure 2. Effect of glutathione (GSH) on chromatographic retention of 2,4-dinitrophenylhydrazine (DNPH)
derivatives of 03-degraded arachidonic acid (AA). AA (30 pM in phosphate-buffered saline with 3H-AA
tracer) was exposed to 0.1 ppm 03 for 30 min, solutions incubated with 0, 1, 10, or 100 mM GSH or 10 mM
GSH and GSH peroxidase (60 min at370C), and then solutions were incubated with DNPH (60 min) before
injection into HPLC system 1. Typical chromatograms are shown. (A) 03-exposed AA incubated with 0
mM GSH (n=3), (B) 1 mM GSH (n= 2), (C) 10 mM GSH (n= 3), (D) 100 mM GSH (n= 3), and (E) 10 mM GSH
plus GSH peroxidase (5 U/mI) (n= 2).
almost all of peaks III, IV, and V (88%,
94%, and 89% decrease, respectively) with
a concomitant 555% increase in radioac-
tivity in peak II and no change in peak II
(Fig. 2D). Incubation ofthe 03-degraded
AA with both 10 mM GSH and GSH per-
oxidase (5 U/ml) did not reduce peaks
III-V beyond that seen with 10 mM GSH
alone (Fig. 2E). In separate experiments,
100 mM GSH did not react with DNPH.
Therefore, the decrease in peaks Ill-V
upon incubation of 03-exposed AA with
10 or 100 mM GSH was not due to a
GSH-induced interference with the reac-
tion ofDNPH with carbonyl groups.
Exposure ofeither PBS or AA (30 IM
in PBS) to air for up to 120 min resulted
in the production of H202 at concentra-
tions <4 jM (Table 1). PBS exposed to
0.1 ppm 03 (for 30 min) resulted in the
production of a low amount of H202'
Exposure ofPBS to a higher concentration
and duration of03 (1.0 ppm for 120 min)
increased the H202 concentration to 8.7
pM. In contrast, exposure of AA to 0.1
ppm 03 (30 min) resulted in an H202
concentration that was 9.4-fold higher
than that found with the 03 exposure of
PBS alone (20.8 piM versus 2.2 pM H202;
p<O.O5). Similarly, exposure ofAA to 1.0
ppm for 120 min resulted in a 5.6-fold
higher concentration of H202 than com-
pared to 03 exposure of PBS alone (48.9
pM versus 8.7 IM;p<0.05). Less than 0.1
pjM (cumene hydroperoxide-equivalents)
of organic peroxide was detected upon
incubation of the 03-exposed AA (0.1
ppm for 30 min or 1.0 ppm for 120 min)
with MCDP.
Formation ofAA-derivedAldehydes by
BEAS-S6 Cells
To examine ifbronchial epithelial cells, cell
types that are likely to be exposed to 03,
could also produce AA-derived aldehydic
substances in response to 0 exposure, we
prelabeled BEAS cells witi 3H-AA and
exposed them to air or 03. The condi-
tioned media supernatants (apical and
basolateral supernatants that were kept sep-
arate) from air and 03-exposed BEAS-S6
cells were then incubated with either
DNPH or vehicle alone. HPLC analysis
(system 2) demonstrated that air-exposed
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Table 1. Effect of 03 on H202 concentration of phosphate-buffered saline (PBS) and arachidonic acid
(AA) solutions
Exposure Solution Exposure time (min) Concentration H202(4M)
Air PBS 30 1.0±0.4
AA 30 1.0±0.6
Air PBS 120 1.9±1.2
AA 120 3.8±0.6
03 0.1 ppm PBS 30 2.2±0.8
AA 30 20.8±4.6*
031.0 ppm PBS 120 8.7±1.3
AA 120 48.9±8.8*
PBS or AA (30 jM in PBS) were exposed to air or 03 either for 30 or 120 min. After exposure, solutions
were removed from the chambers, and H202 concentrations were determined by the horseradish peroxi-
dase-mediated oxidation of phenol red. Values representthree separate experiments.
*Significant difference from paired 03-exposed PBS value.
cells released primarily 3H-AA (at 83 min)
and 3H-phospholipids (in the solvent
front) into the basolateral compartment
(Fig. 3A) and into the apical compartment
(data not shown). This radioactivity did
not shift retention time when incubated
with DNPH. In contrast to the air-
exposed cells, BEAS cells exposed to 0.1
?pm 03 (1 hr) had an increased release of
H products into the basolateral compart-
ment, with the largest product being a rela-
tively polar peak that eluted early in the
HPLC run (Fig. 3B). Incubation of the
supernatant from the basolateral compart-
ment of 0.1 ppm 03-exposed BEAS cul-
tures with DNPH resulted in a shift of
some tritium into products that eluted at a
retention time ofapproximately 63 and 83
min. A similar profile of3H-AA products
was released into the apical compartment
by 0.1 ppm 03-exposed cells, but no
increased radioactivity in any peaks was
observed in the apical supernatant incubat-
ed with DNPH (data not shown). Similar
to the 0.1 ppm 03-exposed cultures, 1.0
ppm 03-exposed BEAS cells also released a
radioactive polar peak as the major product
into the basolateral compartment (Fig.
3C). In contrast to the 0.1-ppm exposure
group, incubation of the basolateral super-
natant from 1.0 ppm 03-exposed cells
with DNPH resulted in a shift of tritium
into several peaks that eluted at 26, 42, 63,
66, and 83 min. The polar peak also was
the largest peak released into the apical
compartment of 1.0 ppm 03-exposed cells,
and incubation ofapical supernatants with
DNPH also caused a shift in radioactivity
with increased peaks at 26, 63, and 83 min
(data not shown). The retention times of
the five major peaks formed by 03-ex-
posed AA (0.1 ppm for 30 min) when
reacted with DNPH and separated in
HPLC system 2 are shown in Figure 3D as
a reference. Some of the 03-degraded AA
peaks formed in the cell-free system that
reacted with DNPH (i.e., 63 and 83 min
retention) had similar retention times as
DNPH-reactive products formed by 1.0
ppm 03-exposed BEAS cells.
Because 3H-AA elutes at 83 min in
HPLC system 2, we performed experi-
ments to eliminate the possibility that the
increased radioactivity that eluted at 83
min upon incubation of the supernatants
from 0.1 ppm and 1.0 ppm 03-exposed
BEAS cells with DNPH was not due to an
increased recovery of3H-AA. 14C-AA was
added to the supernatants from 1.0 ppm
03-exposed cultures just before incubation
with either DNPH or vehicle and then
injected into the HPLC system. Recovery
ofthe 14C-AA from the supernatants incu-
bated with or without DNPH was 29,471
dpm and 29,389 dpm in the apical com-
partment extracts, respectively, and 27,524
dpm and 28,994 dpm in the basolateral
compartment extracts, respectively. These
data imply that 1) radioactive AA is not
recovered in increased quantities upon
incubation with DNPH and 2) the in-
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creased radioactivity at 83 min in the
BEAS media that reacted with DNPH was
aldehydic in nature.
BEAS cells exposed to air or 03 (either
0.1 or 1.0 ppm) for 60 min had nonde-
tectable concentrations of lipid peroxides
(<0.1 PM cumene hydroperoxide-equiva-
lents) in the media of both the apical and
basolateral compartments (data not shown;
n = 2). H202 concentrations in the media
ofair-exposed and 03-exposed&BEAS cells
were < 1 pM and < 2 p.M, respectively (n =
4; p = NS).
In vitroAssessment ofBiological
Activity of03-exposed AA
To assess the chemotactic/chemokinetic
property of the degradation products of
03-exposed AA, the ability of 0 -exposed
AA to induce human PMN polarization
(shape change) was studied. Incubating
PMN with PBS for 10 min polarized 15 ±
2% of the cells (Table 2). Incubation of
PMN with fMLP (100 nM, final concen-
tration) as a positive control increased the
number ofcells undergoing polarization to
79 ± 2% (p<0.05 compared to PBS-incu-
bated controls). AA exposed to 0.1 ppm
03 for 30 min induced polarization of 50
± 5% of the PMN (p<0.05). AA exposed
to 1.0 ppm 03 (for 120 min) induced
polarization of 24 ± 5% PMN (p = NS).
PBS exposed to air or 03 (0.1 or 1.0 ppm)
for up to 120 min did not induce an
increase in PMN polarization. PMN incu-
bated with 03-exposed AA (either 0.1 or
1.0 ppm) were not aggregated, and conse-
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Figure 3. Effect of air or 03 exposure on the formation of 3H-arachidonic acid (AA)-derived aldehydic
products by BEAS-S6 cells. BEAS-S6, prelabeled with 3H-AA, were exposed to air or 03 for 60 min in a
Transwell system with Hank's balanced salt solution present in the basolateral compartment but not in
the apical compartment. Media were removed, extracted, and incubated with 2,4-dinitrophenylhydrazine
(DNPH) or vehicle before injection into HPLC system 2. See text for further details. Arrows indicate
peaks of increased radioactivity in media incubated with DNPH compared to media incubated with vehi-
cle alone. (A) Basolateral media extract of cultures exposed to air. (B) Basolateral media extract of cul-
tures exposed to 0.1 ppm 03. (C) Basolateral media extract of cultures exposed to 1.0 ppm 03. (D) AA
solution (30 \M in phosphate-buffered saline with 3H-AAtracer) exposed to 0.1 ppm 03 for 30 min.
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Table 2. Effect of 03-exposed arachidonic acid (AA) on human PMN polarization
Exposure Solution Time (min) % Polarization n
None PBS 15 ±2 16
Air PBS 30 14±4 9
None 100nMfMLP 79±2* 16
03,0.1 ppm AA 30 50±5* 13
PBS 30 14±2 15
03, 1.0 ppm AA 120 24±13 8
PBS 120 19±10 9
Abbreviations: PMN, polymorphonuclear leukocytes; PBS, phosphate-buffered saline; fMLP, N-formyl-
methionine-leucine-phenylalanine. 5
AA (30 jiM in PBS) or PBS was exposed to air or 03forthe indicated times. PMN (9 x 10 in 0.9 ml Hank's
balanced salt solution) were incubated with solutions (100 pJ) for 10 min at370C with rocking, then forma-
lin was added. Cells were then examined by standard light microscopy counting techniques.
*Significant difference from PBS-incubated control cells, p<0.05
quently cell aggregates did not interfere
with determining polarization and for-
ward-angle light scatter.
Forward-angle light scatter was mea-
sured to further confirm the effect of 03-
exposed AA on inducing a shape change in
PMN. Typical forward-angle light scatter
intensity data histograms are shown in
Figure 4. PMN incubated with 100 nM
fMLP had a 22 ± 3 channel decrease in
mean channel forward-angle light scatter
compared to cells incubated with PBS
A ~~~~~~~-~--- PBS
100 nM fMLP
0 256
B
0
alone (p<0.01). PMN incubated with 03-
exposed PBS (0.1 ppm for 30 min) had a 4
± 3 channel decrease in mean channel for-
ward-angle light scatter intensity (p = NS).
However, PMN incubated with AA that
was previously exposed to 0.1 ppm 03 for
30 min had a decrease in mean channel
forward-angle light scatter intensity of 17 +
2 (p<0.01).
The increase in PMN polarization
induced by 03-exposed AA (0.1 ppm for
30 min) could have been caused by several
of the components. It may be possible
that residual (nondegraded) AA, various
oxygen species, and/or aldehydic sub-
stances contributed to the increased PMN
polarization. Pretreatment of 03-exposed
AA (0.1 ppm for 30 min) with catalase,
SOD, and ethanol before the addition of
the solution to PMN did not attenuate the
increased polarization (Table 3). H202 (3
mM; a concentration relevant to the
amount produced during AA degradation
by 0.1 ppm 03; Table 1) by itselfdid not
induce increased polarization. Nonde-
graded AA can compose up to 2% of the
radioactivity seen in HPLC chromato-
grams of 03-exposed AA. Incubation of
PMN with a similar concentration of AA
that was recovered after an 03 exposure
(30 nM final concentration) did not
increase PMN polarization. At 3 iM, AA
alone increased PMN polarization to 61 ±
9%. Preincubation of PMN with both
indomethacin and nordihydroguauretic
acid (NDGA; 10 mM each, 15 min,
37°C) reduced the polarization induced by
3 iM AA to 28 ± 11%, suggesting that
AA must be metabolized by cyclooxyge-
nase and/or lipoxygenases to induce polar-
ization. However, PMN preincubated
with indomethacin and NDGA (to de-
crease the metabolism ofresidual AA) had
similar polarization upon incubation with
03-degraded AA (50 ± 16%; p<0.05)
compared with untreated PMN incubated
with 03-degraded AA (47 ± 8%). These
data suggest that any residual AA in the
03-exposed AA was not sufficient to
increase PMN polarization and that the
03-degraded AA products, unlike authen-
tic AA, did not need to be metabolized by
cyclooxygenase and/or lipoxygenases to
induce polarization.
Pretreatment of 03-exposed AA with
100 mM GSH (which eliminated most of
the DNPH-reactive peaks III-V; Fig. 2D)
before addition to PMN resulted in a
polarization value (4 ± 1%) similar to PBS
control values (10 ± 4%; p = NS; Fig. 5).
Incubation ofthe 03-exposed AA with 10
mM GSH with or without GSH peroxi-
dase (which partially eliminates peaks
III-V) had no effect on the increase in
PMN polarization. Pretreatment of PBS
with 100 mM GSH had no effect on
PMN polarization (p = NS).
Production of02- by PMN in the pres-
ence of various test solutions was assayed.
PMN (2 x 105) incubated with phorbol
myristate acetate (PMA; 100 ng/ml) pro-
duced 9.6 ± 1.6 nmol 02- (in 1 hr), which
C
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Figure 4. Forward-angle light scatter (FALS) flow
cytometric analysis of human polymorphonuclear
leukocytes (PMN) incubated with 03-exposed
solutions. PMN were incubated (10 min, 370C)
with phosphate-buffered saline (PBS), N-formyl-
methionine-leucine-phenylalanine (fMLP; 10-7 M
final concentration), 03-exposed PBS (0.1 ppm for
30 min), or 03-exposed AA (0.1 ppm for 30 min)
and then fixed in formaldehyde. Cells were then
analyzed by flow cytometry for changes in FALS.
See textfor more details. PMN incubated with (A)
fMLP, (B) 03-exposed PBS, and (C) 03-exposed
AA. Flow cytometric FALS of PMN incubated
with PBS as a control are shown in each figure
as a reference population. Data aretypical of n=
4 independent experiments.
Table 3. Effect of 03-exposed arachidonic acid (AA) components on PMN polarization
Preincubation
Solution Solution PMN %Polarization n
PBS None None 15±3 6
fMLP,lOOnM None None 81 ±3* 6
03-AA None None 47 ±8* 6
PBS CAT+SOD+EtOH None 27±5 3
03-AA CAT+SOD+EtOH None 56± 10* 3
H202 3jM None None 16±1 4
AA, 0nM None None 18±4 3
AA,3jM None DMSO 61 ±9* 3
AA, 3 M None INDO+NDGA 28±11 3
03-AA None INDO+NDGA 50± 16* 3
Abbreviations: PMN, polymorphonuclear leukocytes; PBS, phosphate-buffered saline; fMLP, N-formyl-
methionine-leucine-phenylalanine; CAT, catalase; SOD, superoxide dismutase; EtOH, ethanol; DMSO,
dimethylsulfoxide; INDO, indomethacin; NDGA, nordihydroguauretic acid.
Solutions were prepared as described in Methods. AA (30 pM) was exposed to 0.1 ppm for 30 min.
Concentrations stated are final concentrations. In some instances, PBS and 03-exposed AA (03-AA)
solutions were pretreated with CAT (120 U/ml), SOD (107 U/ml), and EtOH (1 mM) for 1 hr at370C before
addition to PMN. In some experiments, PMN (in PBS) were preincubated with INDO and NDGA in DMSO
or DMSO alone (15 min,370C, with rocking) before incubation with test solutions.
*Significant difference from PBS-incubated cells, p<0.05
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Figure 5. Effect of glutathione (GSH) on 03-exposed arachidonic acid (AA) induction of polymorphonu-
clear leukocyte (PMN) polarization. We pretreated 900 p1 of 03-exposed AA (0.1 ppm for 30 min) with 0,
10, or 100 mM GSH or 10 mM GSH and GSH peroxidase (Px; 5 U/ml) in 0.1 ml (final volume 1.0 ml) for 60
min at 370C. As an additional control, PBS was alsopretreated with 100 mM GSH. We then added 10001
of each solution to PMN and assessed polarization. Significant difference from PBS alone, p<0.05.
was significantly greater than the produc-
tion of 02- by PBS-incubated control cul-
tures (2.6 ± 1.8 nmol; n = 4, p<0.05).
PMN incubated for 60 min with air-
exposed AA (30 min), 03-exposed PBS
(0.1 ppm for 30 min), or 03-exposed AA
(0.1 ppm for 30 min) produced 2.3 ± 0.6,
2.6 ± 1.4, and 3.5 ± 1.0 nmol 02-' respec-
tively, which was similar to the amount
produced by PBS-incubated control cul-
tures. The effect of pretreatment of PMN
with 0 -exposed AA (0.1 ppm for 30 min)
on a subsequent stimulation of 2- produc-
tion by PMA was also examined. There
was no difference in the PMA-stimulated
production of 02- between cells pretreated
(15 min, 370C) with 03-exposed AA and
cells pretreated with vehicle (data not
shown).
T-lymphocyte cultures that were prein-
cubated for 60 min with air-exposed PBS
or AA (120 min) and then subsequently
incubated with either PHA or concanavalin
A had a similar proliferation, as assessed by
3H-thymidine incorporation, as control
cultures incubated with PBS (data not
shown; p = NS). Lymphocytes incubated
with PBS that had been exposed to 0.1
ppm or 1.0 ppm 03 for 15-120 min had a
similar proliferation as cultures incubated
with unexposed PBS (Table 4). In con-
trast, 1.0 ppm 03-exposed AA (for 120
min) decreased lymphocyte PHA-stimulat-
ed and concanavalin A-stimulated prolifera-
tion to 56% and 27% of PBS control val-
ues, respectively (p<0.05). AA exposed to
0.1 ppm 03 for 15 min inhibited con-
canavalin A-stimulated lymphocyte mitoge-
nesis to 76% of control but did not alter
PHA-stimulated mitogenesis. In separate
experiments, the effect of H202 and 02-
on decreased lymphocyte proliferation
induced by 1.0 ppm 03-exposed AA (120
min) was examined. PHA-stimulated lym-
phocyte cultures incubated with 03-ex-
posed AA and catalase and SOD pretreated
03-exposed AA had 17 ± 12% and 12 ±
8% proliferation, respectively, compared to
control cultures. Similarly, concanavalin-A
stimulated T-cells incubated with untreated
and catalase- and SOD-treated 03-exposed
AA had 5 ± 3% and 5 ± 3% ofthe control
proliferation value, respectively. Cultures
incubated with catalase-treated and SOD-
treated 03-exposed PBS (1.0 ppm for 120
min) had similar proliferation as controls
(data not shown).
NK cells were pretreated for 60 min
with test solutions and then incubated with
51Cr-labeled K562 target cells. O3-exposed
AA (either 1.0 ppm for 120 min or 0.1
ppm for 30 min) significantly decreased
NK cytotoxicity to 20 ± 10% and 24 ± 5%
ofPBS-incubated control cultures (p< 0.05;
Table 5). NK cells incubated with PBS
exposed to 03 (0.1 ppm for 30 min or 1.0
ppm for 120 min) did not change NK
killing oftarget cells from control cultures.
In a separate set of experiments, O3-
exposed AA that was preincubated with
catalase and SOD before incubation with
NK cells slightly, but nonsignificantly,
attenuated the decrease in NK cytotoxicity.
Untreated O3-exposed AA (0.1 ppm for 30
min) had 13.7 ± 8.4% ofcontrol NK activ-
ity, whereas catalase-treated and SOD-
treated O3-exposed AA had 32.6 ± 11.9%
ofcontrol NK cytotoxicity (p = NS).
The effect of O3-exposed AA on the
binding ofNK cells to target cells was then
examined as a possible mechanism for the
decreased NK cytotoxicity of target cells.
In a separate set of experiments, NK cells
were incubated with PBS, O3-exposed PBS
(0.1 ppm for 30 min), or O3-degraded AA
(0.1 ppm for 30 min), and binding to
K562 cells was assessed. There was no sig-
nificant change in the percentage ofeffector
cells binding to target cells, as PBS-incubat-
ed NK cells formed 10.4 ± 1.0% conju-
gates, 03-exposed PBS-incubated cells had
11.5 ± 2.0% conjugates, and O3-exposed
AA incubated cells had 9.8 ± 3.1% conju-
gates (n = 3,p = NS).
Discussion
There are several potential sources oflung
AA that can be attacked by exposure to
03. Free AA can exist in the lung lining
fluid after release from lung cells (e.g., alve-
olar macrophages or tracheal epithelial
cells) (38,39). A second source offree AA
in the lung is the 03-induced increase in
free extracellular AA, possibly due to the
stimulation ofvarious phospholipases (40)
and the inhibition of AA reacylation that
Table 4. Effect of 03-exposed arachidonic acid (AA) on human peripheral blood lymphocyte proliferation
03 Exposure time Proliferation
Mitogen (ppm) (min) Solution (%control)
Concanavalin A 1.0 120 PBS 85±10
AA 27±3*
0.1 15 PBS 104±4
AA 76±10*
Phytohemagglutinin 1.0 120 PBS 95±7
AA 56±7*
0.1 15 PBS 114±1
AA 99±7
PBS, phosphate-buffered saline. Solutions were exposed to 03 (0.1 or 1.0 ppm) for either 15 or 120 min.
Lymphocytes were incubated with the solutions (60 min), and cells were subsequently cultured for 72 hr
in the presence of mitogen. Proliferation was then assessed as the amount of3H-thymidine incorporated
by the cultures. Proliferation was compared to cells incubated with unexposed PBS. Concanavalin A-
stimulated and phytohemagglutinin-stimulated control cultures incorporated 1.29 ± 0.09 X 105 dpm and
1.34±0.10 X 105 dpm, respectively (n = 4for all values).
*Significant difference from PBS control culture, p<0.05
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Table 5. Effect of 03-exposed AA on human
peripheral blood natural killer (NK) cell lysis of
K562tumor cells
03 Exposure time NKlysis
Solution (ppm) (min) (% control) n
PBS 0.1 30 108±11 15
AA 0.1 30 24±5* 15
PBS 1.0 120 93±8 10
AA 1.0 120 20± 10* 10
PBS, phosphate-buffered saline. Solutions were
exposed to 03 (0.1 or 1.0 ppm) for either 30 or 120
min. Peripheral blood NK cells were incubated
with the solutions for 60min,,and cells were sub-
sequently incubated with Cr prelabeled K562
cells at different effector:target ratios (50:1 to
1.8:1) for 4 hr at 370C. Release of 51Cr into the
media was measured and lysis expressed as
LU10. PBS-incubated control cultures averaged
35±9 activity units (n= 17).
*Significant difference from PBS-incubated con-
trol cells, p<0.05.
has been demonstrated with H202 (41).
Increased concentrations of AA have been
found in the lung lavages ofrats exposed to
1.1 ppm 03 in vivo (42). Exposure of rat
and human alveolar macrophages (12,
43,44), bovine tracheal epithelial explants
(45), and BEAS-S6 cells (46) to 03 in vitro
results in an increased release ofAA or AA
metabolites, suggesting an increased release
offree AA.
In this study, we exposed AA in a cell-
free aqueous environment to 03 as an in
vitro model for the reaction ofthis polyun-
saturated fatty acid with 03. We have
demonstrated that AA can be degraded by
03 in a cell-free system at concentrations
as low as 0.1 ppm. The major products of
this degradation are aldehydic compounds
(as determined by reaction with DNPH
and separation by HPLC; Fig. 1) and
H202 (Table 1), with only a small amount
of other peroxides formed. More H202
was formed with the longer 03 exposure
period, but less aldehydic substances were
formed. The formation of similar prod-
ucts, i.e., carbonyl compounds and hydro-
gen peroxide (but only small amounts of
hydroperoxides), upon 03 exposure of
oleic acid (2.5 mM) emulsions and dio-
leoyl phosphatidylcholine liposomes (2
mM) in aqueous media has been previous-
ly reported (14,15). 03 can also degrade
some AA metabolites in cell-free systems
into more polar products (12,46), presum-
ably through a mechanism similar to AA
degradation, resulting in formation of car-
bonyl products and H202. Similarly,
other polyunsaturated fatty acids may be
degraded by 03 exposure. Polyunsaturat-
ed fatty acids have been reported to have
high reactivity with 03 relative to other
biological molecules (47), suggesting that
03 can also react relatively well with these
fatty acids in the lung. Exposure of
rodents to 03 in vivo has been reported to
degrade AA in the lung (13). The precise
nature of the AA degradation products in
the rodent lungs were not elucidated
because the degradation products (postu-
lated to include carbonyl compounds and
ozonides) were converted to carboxylic
acids for analysis. It was not known which
lung source ofAA, i.e., intracellular and/or
extracellular, was degraded by 0.
Another source oflungAA that may be
attacked by 03 is AA that is esterified in
phospholipids and neutral lipids in lung
fluid and cells. AA composes 0.4-7.5%
(by weight) of various phospholipids
(including phosphatidylcholine) recovered
by lavage of human lungs (11). In bron-
choalveolar lavage fluid recovered from
healthy human subjects, the concentration
ofAA (both free and esterified) is approxi-
mately 318 nM (G. Hatch, personal com-
munication; 48). After correction for a
dilution factor of 100 in the bronchoalveo-
lar lavage fluid (due to the instillation of
saline to wash out the lining fluid) based
on the urea concentration technique (2), it
is estimated that the concentration ofAA
would be approximately 31.8 pM in epi-
thelial lining fluid. Therefore, we believe
that the AA concentrations used in these
present studies are relevant to physiological
levels in vivo. Furthermore, AAattached at
the C-2 position in phosphatidylcholine
has been shown to be degraded to an aIde-
hyde upon exposure in vitro to 03 (49).
Additionally, increased release of arachi-
donyl-containing phospholipids and neu-
tral lipids from cells has been reported in
rat alveolar macrophages exposed in vitro
to 0.1-1.0 ppm 03 (12), suggesting that
esterified AA may be degraded by 03 out-
side the cells.
Once formed, the persistence of AA-
derived aldehydic substances in the lung
lining fluid would depend on the chemical
stability ofthe aldehydes, the interaction of
the aldehydes with catabolic substances,
uptake into cells, and transport from the
lung. The 03-exposed AA products had
an innate stability, demonstrated by the
fact that <16% ofeach peak was degraded
at room temperature after 24 hr in the
dark. At least some of the aldehydic sub-
stances react with GSH (Fig. 2), although
100 mM GSH is required to react with all
ofthe less polar aldehydes (peaks III-V in
Fig. 2). Concentrations ofGSH in human
epithelial lining fluid from healthy subjects
have been reported to be <0.5 mM (50)
using urea as a reference compound.
These data imply that GSH alone would
not be a likely detoxifying compound for
aldehydes derived from AA once the car-
bonyls have been formed. However, GSH
in conjunction with GSH transferase has
been shown to catabolize aldehydes (51)
and may enhance the degradation of 03-
exposed AA. Additionally, GSH may
modulate the formation ofthese aldehydic
compounds through scavenging 03 direct-
ly, as sulfhydryl-containing groups can
react readily with 03 (47). GSH peroxi-
dase (in the presence of 10 mM GSH) did
not alter the size of peaks III-V (Fig. 2),
indicating these products are not peroxides
and confirming the results of the MCDP
assay that there are few lipid peroxides pre-
sent in 03-degradedAA.
Besides the possible reaction of 03
with polyunsaturated fatty acids in the
lung lining fluid, 03 may directly react
with lung cells. 03 exposure in vivo has
been shown to induce biochemical changes
in human alveolar macrophages recovered
by bronchoalveolar lavage (52) and oxy-
18- gen-18, derived from 0-labeled 03 has
been reported to reach alveolar macro-
phages in vivo (53), suggesting that 03 can
reach distal portions of the lung. Airway
epithelial cells are likely to be exposed to
03 (and/or to the 0 -induced degradation
products formed in the airway lining fluid)
due to the proximal lung location. We
used a human bronchial epithelial cell line
(BEAS) as a model ofairway epithelial cell
exposure to 03. BEAS cells exposed in
vitro to 0.1 ppm and 1.0 ppm 03 for 60
min released aldehydic substances derived
from incorporated H-AA (Fig. 3). Some
of these aldehydic AA products derived
from the BEAS-S6 cells eluted with reten-
tion times similar to AA degraded by 03 in
a cell-free system, suggesting that the prod-
ucts formed in the cell-free model system
have relevance to the study of aldehydic
substances formed by biological systems in
response to 03. There were also some
aldehydic AA products formed upon expo-
sure ofBEAS cells to 03 that did not elute
with similar retention times as AA degrad-
ed in the cell-free system. This may be due
to different kinetics of formation of alde-
hydic products by the cells, and/or the
derivation of aldehydic substances from
cellular phospholipids present in the expo-
sures of BEAS cells (but not free AA) to
03. The production ofonly low levels of
H202 by 0 -exposed BEAS cells suggests
that either the actual mass ofdegraded AA
was too low to detect an increase in H202
and/or the BEAS cells degraded H202 very
quickly.
The exact dosimetry between the 03
reaching bronchial epithelial cells upon in
vivo exposure and in our in vitro exposure
system using BEAS cells is not known.
However, there are two lines of evidence
that suggest that the in vitro exposures
have relevance to in vivo studies. First,
there was a transient, concentration-depen-
dent (0.1-1.0 ppm) decrease in BRAS cell
viability (measured by the release of
chromium-51) upon exposure to 03 (54),
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which may account in part for some ofthe
production of aldehydic substances. Sim-
ilarly, monkeys exposed to 0.5-0.8 ppm
03 in vivo (8 hr/day for 7 days) had a loss
of ciliated cells in the conducting airways
with subsequent hypertrophy and hyper-
plasia of the remaining cells (55,56).
Secondly, we have reported that this cell
type produces a concentration-related
increase in eicosanoids (e.g., thromboxane
B2 and prostaglandin E2) and cytokines
(e.g., IL-6) upon exposure to 03 (0.1-1.0
ppm for 1 hr) (5X, similar to the increased
amounts ofthese eicosanoids and cytokines
found in the bronchoalveolar lavage fluid
recovered from human subjects exposed to
0.1-0.6 ppm 03 for 2.0-6.6 hr (1-3).
In the present study, we examined the
biological activities of the 03-exposed AA
using several different assay systems. As
previously discussed, a PMN influx into
the lungs of 03-exposed humans and
rodents is a hallmark of 03 toxicity. 03-
exposed AA (0.1 ppm for 30 min) induced
an increased polarization in human PMN
(Table 2). The 03 concentration and
exposure duration are important in the
increased polarization, as a 1.0-ppm expo-
sure for 120 min did not cause an in-
creased PMN polarization. This lack of
polarization in the 1.0 ppm 0 exposure
for 120 min correlates with a different pro-
file ofaldehydic AA products formed com-
pared to the 0.1 ppm exposure (Fig. 1).
The change in PMN shape induced by the
03-exposed AA (0.1 ppm for 30 min) was
confirmed by a decrease in the mean chan-
nel forward-angle light scatter ofthe popu-
lation, similar to decreases observed using
another chemoattractant agent, i.e., fMLP
(Fig. 4), and reported by other investiga-
tors (32).
The possible reactants in the solution
of 03-exposed AA (0.1 ppm for 30 min)
were then examined for their contribution
to the increase in PMN polarization (Table
3; Fig. 5). Pretreatment of the 03-AA
with catalase, SOD, and ethanol before
incubation with PMN did not attenuate
the increased polarization, nor did H202
(3 JIM) increase polarization. These data
suggest that H202 and 02- and hydroxyl
radical were not important in this PMN
response. The increased PMN polarization
induced by the 0.1 ppm 03-exposed AA
also did not appear to be due to any resid-
ual AA present for the following reasons:
1) 3 nM AA (equivalent to the maximal
concentration of residual AA observed in
our HPLC chromatograms) did not in-
crease PMN polarization; 2) PMN re-
quired cyclooxygenase and/or lipoxygenase
activity to polarize in response to 3 jM
AA, as indomethacin and NDGA pretreat-
ment decreased AA-induced polarization;
3) in contrast to pure AA, 03-AA appears
to act directly on PMN to induce polariza-
tion without metabolism by cyclooxyge-
nase and/or lipoxygenase, as indomethacin
and NDGA did not alter the increased
polarization; 4) pretreatment of 03-AA
with 100 mM GSH (which eliminates
most ofpeaks III-V; Fig. 2), prevented the
increase in PMN polarization. These data
suggest that the aldehydic products (peaks
III-V) are responsible for the PMN polar-
ization.
The effect of03-exposed AA (0.1 ppm
for 30 min) on human PMN responses
appeared to be specific. 03-exposed AA
increased polarization, but did not increase
the production ofO2-, either unstimulated
or in response to PMA. The effects of 03
exposure on human PMN O2 production
are not known. However, cells recovered
by bronchoalveolar lavage from human
subjects exposed to 0.4 ppm 03 for 2 hr
(primarily macrophages but with approxi-
mately 10% PMN) had no change in
spontaneous or stimulated O2- production
(2,3). Acrolein (5-40 mM), but not
propanal, has been reported to decrease
human and rat PMN spontaneous and
PMA-stimulated O2- production (58), sug-
gesting that the aldehydic substances of
03-exposed AA either are not structurally
like acrolein (i.e., not o,f3-unsaturated
aldehydes like acrolein), or are not pro-
duced in high enough concentrations to
inhibit PMN O2- generation.
Human peripheral blood T-cells have
been shown to have a decreased mitogen-
stimulated proliferative response upon
exposure to 03 in vivo (4-6). We have
demonstrated that 03-exposed AA (1.0
ppm for 120 min) decreased mitogenesis
in response to PHA and concanavalin A
(Table 4). This decrease in T-cell prolifer-
ation was not due to decreased lymphocyte
viability. AA exposed to less 03 (i.e., 0.1
ppm for 30 min) induced a significant
decrease in concanavalin A-stimulated pro-
liferation, but not in PHA-stimulated
mitogenesis. This differential effect of 0.1
ppm 03-exposed AA on concanavalin A-
stimulated proliferation may be due to a
decreased function of monocytes (which
are needed as an accessory cell to a greater
extent in concanavalin A-induced T-cell
proliferation compared to PHA-induced
proliferation) upon exposure to 03-ex-
posed AA (7-). These data regarding T-cell
mitogenesis are similar to the PMN polar-
ization data in that the profile ofAA degra-
dation products formed (Fig. 1) affects the
magnitude ofbiological response. Neither
H202 nor O2- appear to play a role in the
inhibition of lymphocyte proliferation
induced by 03-exposed AA (1.0 ppm for
120), as pretreatment with catalase and
SOD did not attenuate the decreased
mitogenesis. These data suggest that the
aldehydic substances are responsible for the
decreased T-cell response. In support of
this, 5-nitro-2-nitrofuraldehdye (at <35
,uM) has been shown to almost totally
inhibit human blood T-cell proliferation
(59).
Both 0.1 ppm (for 30 min) and 1.0
ppm (for 120 min) 03-exposed AA de-
creased human peripheral blood NK lysis
of K562 tumor target cells to a similar
extent (Table 5). There was no decrease in
NK viability upon incubation with 03-
exposed AA, implying that an alteration in
NK cell viability was not the mechanism
responsible for decreased target cell lysis.
H202 and/or 02- may be partially in-
volved in the decreased lysis oftarget cells,
as pretreatment ofthe 03-exposed AA (0.1
ppm for 30 min) with catalase and SOD
only slightly (approximately 20%), but
nonsignificantly, attenuated the decreased
cytotoxicity. H202 has been shown to
decrease NK activity toward K562 target
cells (20). The mechanism involved in the
decreased NK cytotoxicity toward K562
cells appeared to involve a step in the lytic
portion of NK cytotoxicity and not the
binding phase because 03-exposed AA had
no effect on the attachment of the effector
cells to the target cells.
In summary, we have shown that AA
can be almost completely degraded by 03
in an aqueous environment at concentra-
tions as low as 0.1 ppm for 30 min. The
major products formed by this degradation
process are primarily aldehydic substances
and H202' Similar aldehydic products are
formed when bronchial epithelial cells are
exposed to 03 in vitro. These aldehydic
products possess bioactivity as evidenced
by increased PMN polarization, decreased
peripheral blood T-cell mitogenesis, and
decreased NK cytotoxicity, which may play
a role in the responses to 03 exposure.
The presence of these degradation prod-
ucts in the lung and the association of the
03-exposed AA with altered lung function
remain to be determined.
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